<DOC>
	<DOC>NCT00510913</DOC>
	<brief_summary>A study to compare the conversion to Prograf® (tacrolimus) to the continuation of cyclosporine in patients at risk for chronic renal allograft failure</brief_summary>
	<brief_title>A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure</brief_title>
	<detailed_description>A two arm study (1 Active, 1 Active control) to compare the incidence, progression and severity of chronic renal allograft failure in at-risk patients who are converted from cyclosporine-based to tacrolimus-based immunosuppression to patients who remain on cyclosporine-based therapy</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Patient has been on cyclosporinebased immunosuppression regimen since the transplant Patient has at least one predefined risk factor for chronic allograft failure Patient is dialysis dependent Patient is recipient of a solid organ transplant other than the kidney</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Treatment efficacy</keyword>
	<keyword>Transplantation rejection</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Cyclosporine</keyword>
	<keyword>tacrolimus</keyword>
</DOC>